Medpace has again been recognized with CRO Leadership Awards from Life Science Leader magazine. This year, Medpace received five awards across all categories including Capabilities, Compatibility, Expertise, Quality, and Reliability across all three groups of respondents (Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma).
For the 2021 CRO Leadership Awards, Clinical Leader and Life Science Leader have once again teamed up with Industry Standard Research (ISR) to determine the award recipients. 60 contract research organizations were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey.
Survey participants were recruited from Pharma and Biopharma companies of all sizes and were screened for decision-making influence related to working with contract research organizations. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.
Medpace won a 2021 CRO Leadership Award in the following categories:
“Medpace is honored to be recognized across all categories for leadership in our industry,” commented Todd Meyers, vice president of business development and marketing. “Our high-science approach to clinical development requires teams of experts working collaboratively to execute complex trials as seamlessly and efficiently as possible. These awards reflect their commitment to our mission to accelerate the advancement of safe and effective medical therapeutics.”
“Selecting the right CRO can make or break your project, says Ed Miseta, chief editor for Clinical Leader. “It can lead to a successful regulatory submission and approval or cost you a lot of time and effort on a failed study. That makes CRO selection a stressful decision for any clinical operations manager. Regardless of whether you are concerned about compatibility, capabilities, expertise, quality, or reliability. We believe our CRO Leadership Awards will help managers with their search process and hopefully help to connect them with the right contract partner. We are grateful to our colleagues at Industry Standard Research for conducting the research necessary to produce these awards. These award winners have proven themselves to be the top service providers in each category. I congratulate all of them for work ethic they exhibit in consistently meeting the needs of their drug development clients.”
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,900 people across 40 countries